These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9117424

  • 1. Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.
    Hall ED, Andrus PK, Oostveen JA, Althaus JS, VonVoigtlander PF.
    Brain Res; 1996 Dec 02; 742(1-2):80-8. PubMed ID: 9117424
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons.
    Andrus PK, Fleck TJ, Oostveen JA, Hall ED.
    J Neurosci Res; 1997 Mar 15; 47(6):650-4. PubMed ID: 9089214
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 15; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 4. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D.
    BMC Biol; 2004 Oct 11; 2():22. PubMed ID: 15473914
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
    Joyce JN, Presgraves S, Renish L, Borwege S, Osredkar T, Hagner D, Replogle M, PazSoldan M, Millan MJ.
    Exp Neurol; 2003 Nov 11; 184(1):393-407. PubMed ID: 14637109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.
    Ling ZD, Robie HC, Tong CW, Carvey PM.
    J Pharmacol Exp Ther; 1999 Apr 11; 289(1):202-10. PubMed ID: 10087005
    [Abstract] [Full Text] [Related]

  • 16. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice.
    Zou L, Xu J, Jankovic J, He Y, Appel SH, Le W.
    Neurosci Lett; 2000 Mar 10; 281(2-3):167-70. PubMed ID: 10704769
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
    Zou L, Jankovic J, Rowe DB, Xie W, Appel SH, Le W.
    Life Sci; 1999 Mar 10; 64(15):1275-85. PubMed ID: 10227583
    [Abstract] [Full Text] [Related]

  • 18. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J, Afonso-Oramas D, Cruz-Muros I, Salas-Hernández J, Barroso-Chinea P, Moratalla R, Millan MJ, González-Hernández T.
    Neurobiol Dis; 2015 Feb 10; 74():325-35. PubMed ID: 25511804
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective properties of the benzodiazepine receptor, partial agonist PNU-101017 in the gerbil forebrain ischemia model.
    Hall ED, Andrus PK, Fleck TJ, Oostveen JA, Carter DB, Jacobsen EJ.
    J Cereb Blood Flow Metab; 1997 Aug 10; 17(8):875-83. PubMed ID: 9290585
    [Abstract] [Full Text] [Related]

  • 20. Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
    Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH, Jenner P.
    Exp Neurol; 2008 Aug 10; 212(2):522-31. PubMed ID: 18571649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.